Innate Immune Responses to West Nile Virus Infection

[1]  I. Campbell,et al.  Role of IFN‐γ in an experimental murine model of West Nile virus‐induced seizures , 2007 .

[2]  Felicia D Gilfoy,et al.  Differential Activation of Human Monocyte-Derived and Plasmacytoid Dendritic Cells by West Nile Virus Generated in Different Host Cells , 2007, Journal of Virology.

[3]  Ruth R. Montgomery,et al.  Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. , 2007, The Journal of clinical investigation.

[4]  S. Paik,et al.  Crystal Structure of the TLR1-TLR2 Heterodimer Induced by Binding of a Tri-Acylated Lipopeptide , 2007, Cell.

[5]  Hayyoung Lee,et al.  Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran , 2007, Cell.

[6]  Felicia D Gilfoy,et al.  West Nile Virus-Induced Interferon Production Is Mediated by the Double-Stranded RNA-Dependent Protein Kinase PKR , 2007, Journal of Virology.

[7]  C. Power,et al.  West Nile Virus-Induced Neuroinflammation: Glial Infection and Capsid Protein-Mediated Neurovirulence , 2007, Journal of Virology.

[8]  M. Diamond,et al.  Cell-Specific IRF-3 Responses Protect against West Nile Virus Infection by Interferon-Dependent and -Independent Mechanisms , 2007, PLoS pathogens.

[9]  L. Leng,et al.  Macrophage migration inhibitory factor induces MMP-9 expression in macrophages via the MEK-ERK MAP kinase pathway. , 2007, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[10]  M. Gale,et al.  Principles of intracellular viral recognition. , 2007, Current opinion in immunology.

[11]  D. Davies,et al.  The molecular structure of the TLR3 extracellular domain , 2006, Journal of endotoxin research.

[12]  M. Degli-Esposti,et al.  Natural killer cells in viral infection: more than just killers , 2006, Immunological reviews.

[13]  R. Doms,et al.  The Location of Asparagine-linked Glycans on West Nile Virions Controls Their Interactions with CD209 (Dendritic Cell-specific ICAM-3 Grabbing Nonintegrin)* , 2006, Journal of Biological Chemistry.

[14]  K. Shirato,et al.  The kinetics of proinflammatory cytokines in murine peritoneal macrophages infected with envelope protein-glycosylated or non-glycosylated West Nile virus. , 2006, Virus research.

[15]  M. Diamond,et al.  Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion , 2006, Journal of Virology.

[16]  A. Barrett,et al.  γδ T Cells Facilitate Adaptive Immunity against West Nile Virus Infection in Mice1 , 2006, The Journal of Immunology.

[17]  E. Morand,et al.  Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis , 2006, Arthritis research & therapy.

[18]  Anantha Marri,et al.  PKR and RNase L Contribute to Protection against Lethal West Nile Virus Infection by Controlling Early Viral Spread in the Periphery and Replication in Neurons , 2006, Journal of Virology.

[19]  M. Diamond,et al.  Gamma Interferon Plays a Crucial Early Antiviral Role in Protection against West Nile Virus Infection , 2006, Journal of Virology.

[20]  Richard A Flavell,et al.  Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Rodríguez-Fernández,et al.  DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production. , 2006, Blood.

[22]  K. Ishii,et al.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.

[23]  D. Garcia-Tapia,et al.  Replication of West Nile virus in equine peripheral blood mononuclear cells. , 2006, Veterinary immunology and immunopathology.

[24]  I. Hewlett,et al.  Monocytes‐macrophages are a potential target in human infection with West Nile virus through blood transfusion , 2006, Transfusion.

[25]  R. Flavell,et al.  Microglia Recognize Double-Stranded RNA via TLR31 , 2006, The Journal of Immunology.

[26]  R. Silverman,et al.  RNase L Plays a Role in the Antiviral Response to West Nile Virus , 2006, Journal of Virology.

[27]  M. Gale,et al.  West Nile Virus Evades Activation of Interferon Regulatory Factor 3 through RIG-I-Dependent and -Independent Pathways without Antagonizing Host Defense Signaling , 2006, Journal of Virology.

[28]  D. Davies,et al.  The dsRNA binding site of human Toll‐like receptor 3 , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[29]  K. Tyler,et al.  CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis , 2006, Neurology.

[30]  Shizuo Akira,et al.  Innate immune recognition of viral infection , 2006, Nature Immunology.

[31]  R. Doms,et al.  West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and Infection , 2006, Journal of Virology.

[32]  C. Sturgis,et al.  Cerebrospinal fluid cytology in seasonal epidemic West Nile virus meningo‐encephalitis , 2006, Diagnostic cytopathology.

[33]  M. Diamond,et al.  West Nile Virus from Infected Neurons T Cells Require Perforin to Clear + Cd8 , 2022 .

[34]  I. Michelow,et al.  The mannose-binding lectin: a prototypic pattern recognition molecule , 2005, Current Opinion in Immunology.

[35]  M. Cheeran,et al.  Differential responses of human brain cells to West Nile virus infection , 2005, Journal of NeuroVirology.

[36]  R. Bucala,et al.  Macrophage migration inhibitory factor. , 2005, Critical care medicine.

[37]  M. Diamond,et al.  Alpha/Beta Interferon Protects against Lethal West Nile Virus Infection by Restricting Cellular Tropism and Enhancing Neuronal Survival , 2005, Journal of Virology.

[38]  L. Leng,et al.  Role for macrophage migration inhibitory factor in asthma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  B. Franke,et al.  Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. , 2005, Arthritis and rheumatism.

[40]  I. Wilson,et al.  Crystal Structure of Human Toll-Like Receptor 3 (TLR3) Ectodomain , 2005, Science.

[41]  F. Nicoletti,et al.  Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes. , 2005, Endocrinology.

[42]  R. Doms,et al.  An infectious West Nile virus that expresses a GFP reporter gene. , 2005, Virology.

[43]  E. Fikrig,et al.  Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis , 2004, Nature Medicine.

[44]  A. Iwasaki,et al.  Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.

[45]  Akiko Iwasaki,et al.  Recognition of single-stranded RNA viruses by Toll-like receptor 7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Shizuo Akira,et al.  Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.

[47]  R. Flavell,et al.  Shielding the double‐edged sword: negative regulation of the innate immune system , 2004, Journal of leukocyte biology.

[48]  T. Hibi,et al.  Association of the −173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis , 2004, Journal of Gastroenterology.

[49]  N. King,et al.  Major histocompatibility complex class I (MHC-I) induction by West Nile virus: involvement of 2 signaling pathways in MHC-I up-regulation. , 2004, The Journal of infectious diseases.

[50]  T. Compton,et al.  Human Cytomegalovirus Elicits a Coordinated Cellular Antiviral Response via Envelope Glycoprotein B , 2004, Journal of Virology.

[51]  K. Schroder,et al.  Interferon‐γ: an overview of signals, mechanisms and functions , 2004 .

[52]  T. Calandra,et al.  Macrophage migration inhibitory factor: a regulator of innate immunity , 2003, Nature Reviews Immunology.

[53]  E. Fikrig,et al.  IFN-γ-Producing γδ T Cells Help Control Murine West Nile Virus Infection 1 , 2003, The Journal of Immunology.

[54]  S. Akira,et al.  Toll-like Receptor 9–mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells , 2003, The Journal of experimental medicine.

[55]  S. Akira,et al.  Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway , 2003, Science.

[56]  B. Seliger,et al.  Upregulation of Major Histocompatibility Complex Class I on Liver Cells by Hepatitis C Virus Core Protein via p53 and TAP1 Impairs Natural Killer Cell Cytotoxicity , 2003, Journal of Virology.

[57]  N. King,et al.  Interaction of flaviviruses with cells of the vertebrate host and decoy of the immune response , 2003, Immunology and cell biology.

[58]  R. Prayson,et al.  The neuropathology of West Nile virus meningoencephalitis. A report of two cases and review of the literature. , 2003, American journal of clinical pathology.

[59]  R. Prayson,et al.  The Neuropathology of West Nile Virus Meningoencephalitis , 2003 .

[60]  E. O. Shishkina,et al.  Morphofunctional Characteristics of Antigen-Presenting Cells in Lymph Node in Mice with Experimental West Nile Fever , 2003, Bulletin of Experimental Biology and Medicine.

[61]  T. Geijtenbeek,et al.  Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function , 2003, The Journal of experimental medicine.

[62]  Bei Yue,et al.  Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis. , 2002, Hepatobiliary & pancreatic diseases international : HBPD INT.

[63]  G. Wennemuth,et al.  Release of Macrophage Migration Inhibitory Factor and CXCL8/Interleukin-8 from Lung Epithelial Cells Rendered Necrotic by Influenza A Virus Infection , 2002, Journal of Virology.

[64]  C. Samuel,et al.  Host genetic variability and West Nile virus susceptibility , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[65]  L. Petersen,et al.  West Nile Virus: A Primer for the Clinician , 2002, Annals of Internal Medicine.

[66]  D. Gemsa,et al.  Human cytomegalovirus-mediated induction of MIF in fibroblasts. , 2002, Virology.

[67]  Elias Lolis,et al.  The Tautomerase Active Site of Macrophage Migration Inhibitory Factor Is a Potential Target for Discovery of Novel Anti-inflammatory Agents* , 2002, The Journal of Biological Chemistry.

[68]  S. Carding,et al.  γδ T cells: functional plasticity and heterogeneity , 2002, Nature Reviews Immunology.

[69]  P. Gregersen,et al.  A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis , 2002, Genes and Immunity.

[70]  Peter D. Senter,et al.  Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[71]  Lisheng Wang,et al.  Human Vγ2Vδ2 T Cells Produce IFN-γ and TNF-α with an On/Off/On Cycling Pattern in Response to Live Bacterial Products1 , 2001, The Journal of Immunology.

[72]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[73]  G. Halliday,et al.  Interleukin-1β But Not Tumor Necrosis Factor is Involved in West Nile Virus-Induced Langerhans Cell Migration from the Skin in C57BL/6 Mice , 2001 .

[74]  Douglas T. Golenbock,et al.  Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus , 2000, Nature Immunology.

[75]  N. Abbott.  Inflammatory Mediators and Modulation of Blood–Brain Barrier Permeability , 2000, Cellular and Molecular Neurobiology.

[76]  Xin-Yuan Fu,et al.  Dominance of IL-12 Over IL-4 in γδ T Cell Differentiation Leads to Default Production of IFN-γ: Failure to Down-Regulate IL-12 Receptor β2-Chain Expression1 , 2000, The Journal of Immunology.

[77]  G. Halliday,et al.  Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus. , 2000, The Journal of investigative dermatology.

[78]  R. Bucala,et al.  Protection from septic shock by neutralization of macrophage migration inhibitory factor , 2000, Nature Medicine.

[79]  E. Gold,et al.  The macrophage--a cell for all seasons. , 1999, Trends in cell biology.

[80]  Y. L. Lin,et al.  Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication , 1997, Journal of virology.

[81]  B. Lemaître,et al.  The Dorsoventral Regulatory Gene Cassette spätzle/Toll/cactus Controls the Potent Antifungal Response in Drosophila Adults , 1996, Cell.

[82]  G. Halliday,et al.  Phenotypic changes in Langerhans' cells after infection with arboviruses: a role in the immune response to epidermally acquired viral infection? , 1996, Journal of virology.

[83]  M. Eibl,et al.  Nitric oxide and viral infection: NO antiviral activity against a flavivirus in vitro, and evidence for contribution to pathogenesis in experimental infection in vivo. , 1996, Virology.

[84]  A. Müllbacher,et al.  Functional analysis of macrophages, B cells and splenic dendritic cells as antigen‐presenting cells in West Nile virus‐specific murine T lymphocyte proliferation , 1991, Immunology and cell biology.

[85]  N. King,et al.  Induction of class I major histocompatibility complex antigen expression by West Nile virus on gamma interferon-refractory early murine trophoblast cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[86]  Yang Liu,et al.  Flavivirus infection up-regulates the expression of class I and class II major histocompatibility antigens on and enhances T cell recognition of astrocytes in vitro , 1989, Journal of Neuroimmunology.

[87]  N. King,et al.  West Nile Virus Infection Modulates the Expression of Class I and Class II MHC Antigens on Astrocytes in Vitro , 1988, Annals of the New York Academy of Sciences.

[88]  Semenov Bf,et al.  Changes of natural killer cell activity in different mouse lines by acute and asymptomatic flavivirus infections. , 1986 .

[89]  J. David.  Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. , 1966, Proceedings of the National Academy of Sciences of the United States of America.

[90]  R. Steinman,et al.  Dendritic cells: translating innate to adaptive immunity. , 2006, Current topics in microbiology and immunology.

[91]  Trai-Ming Yeh,et al.  Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. , 2006, The American journal of tropical medicine and hygiene.

[92]  N. Theodore,et al.  Report of two cases and review of the literature , 2006 .

[93]  D. Ben-Nathan,et al.  West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice , 2005, Archives of Virology.

[94]  B. Beutler,et al.  TYPE I INTERFERONS (/) IN IMMUNITY AND AUTOIMMUNITY , 2005 .

[95]  A. Hayday.  [gamma][delta] cells: a right time and a right place for a conserved third way of protection. , 2000, Annual review of immunology.

[96]  S. Saxena,et al.  Degradation of Japanese encephalitis virus by neutrophils. , 1999, International journal of experimental pathology.